| Database ID | Agent | Target | Cancer Type | Detail |
| DB00061 | afatinib | Receptor proteintyrosine kinase erbB2
Epidermal growth factor receptor | lung cancer | view |
| DB00062 | dacomitinib | Epidermal growth factor receptor, Proto oncogene proteinc mdm2, Erbb2 tyrosine kinase receptor | non small cell lung cancer | view |
| DB00063 | dacomitinib | Epidermal growth factor receptor, Proto oncogene proteinc mdm2, Erbb2 tyrosine kinase receptor | non small cell lung cancer | view |
| DB00064 | neratinib | mRNA of human epidermal growth factor receptor 2
Vascular endothelial growth factor receptor 2
Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00065 | rociletinib | epidermal growth factor receptor | non small cell lung cancer | view |
| DB00066 | AZD9291 | Epidermal growth factor receptor | non small cell lung cancer | view |
| DB00067 | crizotinib | Hepatocyte growth factor receptor, ALK, ROS1 | non small cell lung cancer | view |
| DB00068 | crizotinib | Hepatocyte growth factor receptor, ALK, ROS1 | non small cell lung cancer | view |
| DB00069 | crizotinib | Hepatocyte growth factor receptor, ALK, ROS1 | non small cell lung cancer | view |
| DB00070 | ceritinib | ALK | non small cell lung cancer | view |
| DB00071 | alectinib | ALK inhibition including activity againstL1196M, G1269A, C1156Y, and F1174Lmutations | non small cell lung cancer | view |
| DB00072 | alectinib | ALK inhibition including activity againstL1196M, G1269A, C1156Y, and F1174Lmutations | non small cell lung cancer | view |
| DB00073 | selumetinib | Dual specificity mitogenactivated protein kinase kinase | non small cell lung cancer | view |
| DB00074 | trametinib | MEK2
Dual specificity mitogenactivated protein kinase kinase 1 | non small cell lung cancer | view |
| DB00075 | everolimus | Serine/threonineprotein kinase mTOR | non small cell lung cancer | view |